The Public Safety Personnel (PSP) Sleep Course: An Online Sleep Intervention for PSP.
ConditionInsomnia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Regina
About this trial
This study evaluates an internet-delivered cognitive behavioural therapy for insomnia (ICBTi) intervention, known as the Sleep Course, adapted for public safety personnel (PSP) experiencing sleep difficulties. The study seeks to replicate prior results from an Australian version of the Sleep Course assessing its effectiveness and acceptability when offered to PSP.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
18 years of age or older
Current or former paid or volunteer PSP
Living in a province in Canada where PSPNET offers the Sleep Couse for the treatment period
Willingness to learn information and skills to self-manage sleep difficulties
Disqualifiers
Current severe medical or psychiatric disorder (e.g. current and recent mania or psychosis, recent hospitalization for mental health concerns, actively suicidal, medical condition client thinks will interfere with treatment, severe substance use)
Unable to read and understand English. (All content is provided in English and staff is English speaking; pending findings of the research PSPNET will explore translating the course into French)
Trial design
Design model
Single group
Treatments tested in this trial
Sleep Course
BehavioralThe Sleep Course previously developed and evaluated in Australia has been tailored to PSP and will be delivered to clients meeting participation criteria. The Sleep Course has been slightly adapted for PSP by including relevant statistics and literature pertaining to sleep disturbance in PSP. The Sleep Course has four lessons and includes optional therapist support for up to 8 - 12 weeks. Clients who request support will be contacted by their therapist by secure emails on their designated check-in dates. The therapist also reviews client progress in the course and emails clients on a designated check in date. Sometimes the therapist will call the client. Phone calls are typically made if a client is not logging in or if the therapist feels that a phone call would be a helpful way to provide support.
Treatment groups
60 Participants
are divided into 1 treatment groupGroup A: ICBT for insomniaExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Change in insomnia
Insomnia Severity Index (ISI). Includes 7 items rated on a 0 to 5 scale. Higher total scores indicate greater severity of insomnia symptoms over the past two weeks. Scores range from 0 to 28.
Time frame
Screening, week 7 (post-treatment), and 3-month follow-upSecondary outcomes
1
Change in Sleep Quality
Sleep Quality Scale (SQS) is a 1-item survey with total scores ranging from 0-10. Higher scores indicate better overall sleep quality for over the past week.
Time frame
Screening, start of lesson 1 (day 0), start of lesson 2 (day 7), start of lesson 3 (day 21), start of lesson 4 (day 35), and week 7 (post-treatment), and 3-month follow-up2
Change in Sleep-Related Impairment
The PROMIS Sleep Related Impairment Short Form (SRI-SF) scale assesses the impact of sleep disturbances on daytime functioning. There are 8 items, which are related to cognitive, emotional, and social functioning. Responses range from 0 (not at all) to 4 (very much) with total scores ranging from 8-40.
Time frame
Screening, week 7 (post-treatment), and 3 month follow up3
Change in attitudes and beliefs about sleep
Dysfunctional Beliefs and Attitudes about Sleep- 16 item (DBAS-16) with items rated on a 0 to 10-point scale. Scores range from 0 to 160 with higher scores indicating greater dysfunctional beliefs about sleep.
Time frame
Screening, week 7 (post-treatment) and 3-month follow-up4
Change in depression
Patient Health Questionnaire - 9 Item (PHQ-9). Includes 9 items rated 0 to 3. Higher total scores indicate greater severity of depression. Scores range from 0 to 27. Clinical cutoff of ≥10 indicate clinically significant depression.
Time frame
Screening, week 7 (post-treatment) and 3-month follow-upSponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Regina
Lead sponsor
Government of Canada
Collaborator
Source ClinicalTrials.gov